[ExI] Alzheimers again
William Flynn Wallace
foozler83 at gmail.com
Wed Dec 10 19:01:09 UTC 2014
It has become so expensive and so hard
to prove the efficacy of a drug or therapy, we stifle experimentation and
slow progress nearly to a halt.
I read that it takes about 100 Million dollars to get a drug to market.
And even then less than half the studies verifying the drug's efficacy and
safety are done with the gold standard: double-blind studies.
Further, the drug companies are not doing studies with stuff like herbs
because even if they do work they can't patent them.
It's a messed-up system bill w
On Wed, Dec 10, 2014 at 12:12 PM, spike <spike66 at att.net> wrote:
> >... On Behalf Of spike
> >>...Has Stanford University found a cure for Alzheimer's disease?...Keith
> >...We all know it takes years to do a clinical trial, and even then
> ethics notions prevent us from doing plenty of experiments. I have an
> Because if I go down, I want to go down swinging. I want to try
> even if chances are it is useless or even harmful. Better to fight in vain
> than go peacefully, ja? If nothing else, it's our gift to the future, to
> help inform them on what doesn't work, ja?
> My point of all this: with our legal system trying to solve problems like
> wildcat doctors (such as Kellogg) doing ill-advised experiments and killing
> patients, we have set up a stultifying system which has gone so far, it
> might have done more harm than good. It has become so expensive and so
> to prove the efficacy of a drug or therapy, we stifle experimentation and
> slow progress nearly to a halt. We have worked so hard to shut down snake
> oil salesmen that we have stifled most innovative medical technological
> So, we set up a special class where we know what happens if we do nothing,
> such as AD patients. We let that class of willing and eager volunteers do
> whatever they think is right, and absolve their medical teams of any
> responsibility if things go wrong, which they will in nearly every case.
> All we ask is that we have some kind of objective monitoring and feedback
> loop, so the experimental results don't get lost, as they are now with
> experimental AD medications.
> How do we do this?
> extropy-chat mailing list
> extropy-chat at lists.extropy.org
-------------- next part --------------
An HTML attachment was scrubbed...
More information about the extropy-chat